SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " fact " 2,750 found 🔀 AI-powered Shuffle
Citing construction, downtown Noblesville business will close
The Velvet Plum Vintage & Consignment, a home decor and furniture consignment shop at 894 Logan St. in Noblesville, has announced it will close July 15, citing Embrace Downtown construction as the driving factor. The Embrace Downtown project began earlier this year to provide infrastructure a
Citing construction, downtown Noblesville business will close
The Velvet Plum Vintage & Consignment, a home decor and furniture consignment shop at 894 Logan St. in Noblesville, has announced it will close July 15, citing Embrace Downtown construction as the driving factor. The Embrace Downtown project began earlier this year to provide infrastructure a
McArthur Center to prepare University of Rio Grande health care and manufacturing students
A facility at the University of Rio Grande has opened, offering new educational opportunities for students.The McArthur Center features nine modern classrooms a
Illinois 250: What we’ve invented, innovated, created and manufactured
Illinois builds things. We invent and innovate, too — everything from the Pullman car to plastic party cups.
Muslera blunders, sets unwanted Cup record, and socials pounce
In Guadalajara, Mexico, Spain is leading Uruguay 1-0 this Friday (26), in the third round of the group stage of the 2026 FIFA World Cup.La Celeste’s partial defeat, in fact, is securing Cape Verde��...
We almost had a smartphone in the 90s. Why did it fail?
In the early 90’s, a company called General Magic began working on a portable device that would allow people to check email, make phone calls, even play games. It was basically a smartphone. But it never caught on.On today’s show, a theory about why this device failed. General Magic had generous investors, world-class talent and creative freedom. But is it possible what they needed was constraints?Support:Planet Money+Read: Our book: Planet Money: A Guide to the Economic Forces That Shape Your Life Our weekly longform Planet Money newsletterOur weekly Indicator round-up newsletterFollow: InstagramTikTokYouTubeFacebookThis episode was hosted by Erika Beras and Emma Peaslee. It was produced by Emma Peaslee with help from Sam Yellowhorse Kesler and James Sneed. It was edited by Marianne McCune and fact-checked by Charlotte Isidore. It was engineered by Jimmy Keeley with help from Cena Loffredo. Alex Goldmark is Planet Money’s executive producer.
I Went From Bedside Nurse to Business Owner By Turning a Hobby Into a Home Micro-Factory That Makes Over $100K a Year
Eric Street followed his crafting passion into business.
Manufacturing business cuts ribbon in Putnam County, set to bring 120 jobs to area
The operation is a joint venture between global engineering group Sandvik and mining company Alpha Metallurgical Resources.
Factory Entertainment Announces Three More STAR TREK Collectibles, Including Gold-Pressed Latinum Bars
Factory Entertainment today unveiled three more STAR TREK replicas, including bars of gold-pressed latinum and Eline’s necklace from “The Inner Light”
Pacquiao and Mayweather rematch postponed indefinitely
The rematch between boxing greats Manny Pacquiao and Floyd Mayweather has been postponed indefinitely because of a host of reasons, with contract disputes the main factor.
Business Owners Agree: The Road to Downtown Recovery Runs Through Facts, Not Nostalgia
State Street's commercial vacancy rate is lower today than it was before the pandemic. The highest vacancy rates remain on blocks that are open to vehicle traffic.
Robot startup FieldAI achieves $100M milestone in revenue, contracts
FieldAI says it has crossed $100 million in revenue and contracts by building software for robots to work in mines, construction sites, and factories.
Cabo Verde Is a Breakout Star of the World Cup. So Is the Family-Owned Business That Designed Its Jerseys
After more than three decades manufacturing apparel, Capelli Sport co-founder and CEO George Altirs found his company’s biggest billboard yet—3,500 miles away from his midtown Manhattan office.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
CBS Sports named this transfer as a potential X-factor for the Longhorns, and it may not be who you expect
The Longhorns’ CFP hopes could hinge on this transfer addition.
ServiceNow: An Excellent Business Trading at a Discount
ServiceNow is doing everything right, and its stock price should begin to reflect that fact.
Buc-ee’s is finally open in Goodyear. A nearby small business prepares for its impact
As Buc-ee’s opens its first Arizona location in Goodyear, a nearby hot sauce manufacturer and gift shop prepares for an influx of tourists and road-trippers while weighing the impact on local business.
Factory Entertainment Unveils Four 2026 STAR TREK Convention Exclusives, Preorders Open Now
Factory Entertainment’s 2026 convention-exclusive STAR TREK goodies are here, with four new items available for preorder today
Where health begins
Dean Bernadette Boden-Albala has spent her career exploring the factors that affect well-being long before disease develops
20 everyday habits that affect your heart health
Cardiovascular disease is the world's leading cause of death — and most of its risk factors are behavioral, not genetic. These are the daily habits that matter most
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?
Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.
GTA 6 Price, Single Player Revealed Ahead of Pre-orders
Rockstar Games has finally revealed the price for "Grand Theft Auto VI" -- and the fact the game will be a "single-player experience" at launch.
Affordability, not fraud, is why fewer Americans have health insurance
The “fraud, waste, and abuse” narrative has been seriously overworked, and does not fit the facts.
This is the real reason your cat purrs—and it’s not what you think - Futura-Sciences
The Genetic Mystery Behind the Purr If you thought your cat’s purr was just an automatic sound of happiness—like you sighing with satisfaction after a good meal—science begs to differ. Researchers from Kyoto University’s Wildlife Research Center in Japan have identified, for the first time, genetic underpinnings to this ancient...
A staunch voice in support of science
Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research in the face of federal cuts
Trump touts falling oil prices, economy at Pennsylvania rally
The president spoke at a Mack Trucks factory in Macungie on Tuesday
Trump touts falling oil prices, economy at Pennsylvania rally
The president spoke at a Mack Trucks factory in Macungie on Tuesday
Trump touts falling oil prices, economy at Pennsylvania rally
The president spoke at a Mack Trucks factory in Macungie on Tuesday
Science Will Not Save the Abortion Pill : The Hastings Center for Bioethics
The facts are not enough. In addition to using evidence, people who support the legal right to abortion must make the moral case for it.
Offworld Space Biology: Setting Up The Life Science Glovebox
Bioengineering cartilage tissues and manufacturing advanced materials kicked off the week aboard the International Space Station
Why the Covid-19 documents Gabbard released don’t prove her claims about Fauci
On her final day as national intelligence director last week, Tulsi Gabbard released internal documents she claimed prove a series of damning facts about Dr. Anthony Fauci and the Covid-19 pandemic. But they don’t.
US Business Activity Picks Up on Manufacturing Strength
US business activity expanded at the fastest pace in five months, bolstered by a surge in demand for manufactured goods.
Advances in materials science are helping unlock secrets of nanomaterials
New instruments on the horizon promise the most precise tools yet to study and experiment on the smallest and most complex materials ever manufactured. In a paper published in the journal Nature Materials, ...
Mamdani and AI industry flex political power in New York, plus more to watch in Tuesday's primaries
Two factions in the AI industry are clashing in a Democratic primary for a U.S. House seat. New York Assemblyman Alex Bores, a pro-regulation candidate, faces opposition from a group funded by OpenAI investors. The group spent over $7 million on ads against him. In response, groups partly backed ...
Mamdani and AI industry flex political power in New York, plus more to watch in Tuesday's primaries
Two factions in the AI industry are clashing in a Democratic primary for a U.S. House seat
Mamdani and AI industry flex political power in New York, plus more to watch in Tuesday's primaries
Two factions in the AI industry are clashing in a Democratic primary for a U.S. House seat.
Mamdani and AI Industry Flex Political Power in New York, Plus More to Watch in Tuesday's Primaries
WASHINGTON (AP) — Two opposing factions in the artificial intelligence industry square off in a Democratic primary for a U.S. House seat. New York City Mayor Zohran Mamdani tests his political clout by backing fellow democratic socialists. And President Donald Trump, after two of his chosen ...
Mill Avenue businesses brace for recovery as construction nears the end
After months of construction being just one factor keeping customers away from Mill Avenue businesses, places that have made it through hope a rebound is coming as construction nears its end.
We must support 'strange' science, RNA biologist Jeff Coller writes in The New York Times
Without federal funding, American researchers can't chase scientific questions that may lead to lifesaving cures, Hopkins RNA biologist Jeff Coller writes in 'The New York Times'
Health inspections in first half of 2026 lead to restaurant closures, warnings in Champaign Co.
CHAMPAIGN COUNTY, Ill. (WCIA) — In the first half of the year, more than two dozen businesses in Champaign County have received less than satisfactory health inspections. These businesses hav…
Arkansas Business Announces 2026 Best Places to Work
The annual program highlights 50 employers that stand out for culture, employee satisfaction and organizational practices.
China’s rare earth dominance highlights global supply chain vulnerabilities
China’s dominance in rare earth processing and magnet manufacturing has given it significant influence over global supply chains for products ranging from electric vehicles and wind turbines to consumer electronics and advanced defense systems, The New York Times reports. Although rare earth minerals are mined in several countries, China controls much of the refining and […]
Jet-engine manufacturer plots expansion in Pontiac on site of former movie studio
Williams International is seeking a 15-year extension of its Renaissance Zone tax break to support an expansion.
First Business Bank Funds $1MM Factoring Facility for Transportation Company Growth
First Business Bank’s accounts receivable financing team recently closed a $1 million factoring facility to support the continued growth of a transportation
AORUS RTX 5090 owner checks GPU after higher fan speeds, finds thermal gel mess
A GeForce RTX 5090 AORUS owner has opened the card after more than a year of use (and end of warranty) and found a large amount of factory-applied thermal…
First Business Bank Funds $1MM Factoring Facility for Transportation Company Growth
First Business Bank’s accounts receivable financing team recently closed a $1 million factoring facility to support the continued growth of a transportation
Could China’s next success story be healthcare?
A rapidly ageing population is shifting China’s technological innovation focus from manufacturing towards healthcare.
Don’t worry, a politician can’t present the Today programme. Michael Grade is wrong about that
As the former Ofcom chair says extraordinary things about the rightwing channel and its critics, a factcheck would not go amiss, say Stewart Purvis and Chris Banatvala, both formerly of Ofcom
5 Companies That Make Classic Car Bodies When The Automakers Won't
Some of the companies that build bodies for classic cars when the manufacturer won't include GTO Engineering, Superformance, and Real Deal Steel.
Carolina Panthers X-Factor for 2026 Season Revealed
This player returning from injury was named the Carolina Panthers biggest X-factor for the 2026 season.
Is hearing loss an Alzheimer’s warning sign? Research shows new risk factors
The number of people living with Alzheimer’s disease is expected to double by 2060. New research is shedding light on warning signs and risk factors that could signal cognitive decline ahead.
A Big Change Is Coming to Roku TVs
A big transformations are underway across the Roku TVs home screen as leading manufacturers, including TCL, begin implementing standardized home screen interfaces on their devices. This shift replaces the previous customized designs that each brand had developed independently with the uniform Roku platform experience. The result is a more consistent visual presentation that emphasizes the […]
Ori director says Game Pass ‘could’ve worked’ if Xbox didn’t ‘slop out mediocre content like a factory’
The Moon Studios CEO argues Microsoft has not delivered enough hit games…
Where do Iran’s political factions stand on the US peace deal?
Iran's rival political camps are locking horns over a memorandum of understanding with the US.
Ukraine's war robots are surging into the kill zone
Business Insider went inside a Ukrainian factory building ground robots for deadly missions soldiers can no longer risk.
Rams CB Jaylen Watson named team's X-factor for 2026
The Rams made a lot of moves and have a lot of stars, but this one player could be the deciding factor on how the team performs in 2026.
North Carolina furniture manufacturer allegedly kills business partner hours after losing contract dispute
Scientists expected a black hole but found a neutrino factory powered by stars
A distant galaxy nicknamed Shadow Blaster may have revealed a surprising source of cosmic neutrinos: extreme star formation instead of a supermassive black hole. The discovery suggests that hidden, dust-filled starburst galaxies could account for a significant fraction of the Universe’s high-energy neutrinos.
Glaive Rush Mega Baxcalibur: Greatest Community Day for Raids?
Community Day has always been a redemption arc for several Pokémon, with the popular event propelling them to the top levels of relevance in the PvP and/or PvE meta. In fact, Pseudo Legendaries like Metagross (Meteor Mash) and Hydreigon (Brutal Swing) have literally gone from zero to hero in Pokémon GO via their exclusive moves. […]
Tata's iPhone parts factory faces India health probe after farmer contamination complaints
An Indian state health authority is investigating how liquid discharged from Apple supplier Tata's iPhone components factory has affected farmers, some of whom complained about skin issues from contamination in their farmlands, according to three officials and a document reviewed by Reuters.
In Good Health: The Matter Of Male Fertility
When a couple struggles to conceive, the assumption is often that there is something wrong with the woman. Women are evaluated for infertility far more often than men. But male factor infertility accounts for about half of all infertility cases. And when that’s the case, men are less likely to talk about it, seek support, or even get tested in the first place. In this installment of our “In Good Health” series, we talk about male infertility — what causes it, what can be done about it, and what it’s like to go through it.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
“Shocking and surreal”: What scientists witnessed in the Arctic defies belief - Futura-Sciences
Frontline of Global Warming: The Arctic’s Alarming Transformation The Arctic sits front and center in the battle against climate change—and Svalbard, a Norwegian archipelago at the heart of the region, is feeling its effects more drastically than anywhere else on Earth. In fact, this polar territory is warming six to...
Apple's A12 and A13 Chips Facing New Unpatchable Exploit
Security research firm Paradigm Shift today published details of a new BootROM vulnerability affecting Apple's A12 and A13 chips, along with a working proof-of-concept exploit named "usbliter8". The BootROM, or SecureROM, is the first code an iPhone runs when it powers on. Because it is baked directly into the chip at manufacture, any vulnerability found there cannot be fixed with a software update, meaning affected devices will remain vulnerable for the rest of their lives.
Seth Meyers reminds Donald Trump that the Reflecting Pool is not, in fact, a swimming pool: 'This isn't your chintzy golf club'
The 'Late Night With Seth Meyers' host reminded Donald Trump on Wednesday night that the Reflecting Pool is not a swimming pool. Meyers' quip comes amid costly renovations made to the water feature and comments the president made likening it to a pool at one of his clubs.
Brewer Science to Acquire Semiconductor Chemical Business Line from Heraeus Epurio
Brewer Science, Inc., a global leader in advanced materials and processes for the fabrication of cutting-edge microdevices, today announced it has entered into an agreement to acquire the semiconductor chemicals business line of Heraeus Epurio, a recognized technology leader in ultrapure electronic chemicals used in semiconductor manufacturing. The transaction will include the Heraeus Epurio semiconductor chemicals production site in Dayton, Ohio, along with the associated sales and support pers
Intel Stock Jumps On Reported Apple Chip Business
Intel stock jumped after U.S. President Donald Trump said Apple has reached a chip manufacturing deal with Intel.
Founder of North Carolina furniture business charged after altercation with co-owner ends in deadly shooting
NEWTON, N.C. (QUEEN CITY NEWS) — The founder of a furniture manufacturer in Newton allegedly shot and killed his co-owner following a dispute Wednesday afternoon. Around 3:18 p.m. on June 17,…
Are all redheads born with freckles? Science reveals a surprising truth - Futura-Sciences
Why Rare Redheads Get So Many Stereotypes Redheads are already something of a rarity on this planet—think unicorns but with sunscreen in their bag! In fact, it’s estimated that only about 1 to 2% of the world’s population has natural red hair. The highest concentrations are mainly in Scotland and...
Survey reveals political and cultural factions shaping the midterms
Examine Pew’s survey on types of voters and analyze differences across key political demographic groups
Trump invokes law to increase weapons production after Iran war depleted US stocks
President Donald Trump has invoked the Defense Production Act to force defense companies to manufacture more weapons after the war with Iran depleted stockpiles
Mailbag: Overshown’s health a factor for Green Dot?
Is it a concern at all that DeMarvion Overshown is being considered for Green Dot responsibilities? He has yet to prove he can stay healthy for an entire season.
Is gambling the reason we have pro sports?
To hear author David Bockino tell it, gambling has always been a key ingredient of pro sports in the U.S.—it’s as American as apple pie. Bockino is the author of the new book Over/Under: An Unexpected History of Sports Betting. So what gave rise to this new wave of sports gambling? And what are we risking placing so many bets on games? Fact checking by Sierra Juarez. Your Next Listen — Prediction markets are threatening national security. Who’s gonna fix it? Connect with The Indicator — Sign up for The Indicator’s brand new newsletter — Buy the Planet Money book — Find our socials, YouTube and more! — For sponsor-free episodes, subscribe to NPR+
New plasma trick could unlock smaller, more powerful computer chips
A new technique could solve one of the biggest challenges in making future computer chips from ultrathin materials. Researchers found that coating molybdenum disulfide with oxygen or fluorine lets manufacturers remove just the top layer of atoms much more safely during plasma processing. The result is a cleaner, more controlled path toward smaller and more capable electronics.
Small Business Administration chief talks the state of small businesses in the U.S.
The Reindustrialize Summit convened leaders from manufacturing, technology, defense and finance in Detroit to discuss how to restore America’s industrial strength. Small Business Administration Administrator Kelly Loeffler sat down with CNBC’s Leslie Picker for a conversation on boosting America’s manufacturing base, small business sentiment, and AI’s impact to Main Street.
Healthcare costs are crushing Michigan families; voters are paying attention
Rising healthcare costs are crushing families and will be a deciding factor for Michigan voters in 2026.
Intel takes a major step toward turning around a business that’s bleeding cash
Intel’s new manufacturing process has entered a stage that signals the company is confident in its ability to bring on external customers, analysts say.
Merchants of Doubt and the attacks on Extreme Event Attribution science
Last week, I attended a meeting at Columbia University on attribution science and climate law, hosted by the Sabin Center. It was a fantastic event, bringing together scientists and legal experts working at the intersection of extreme event attribution and climate law. Subscribe For those unfamiliar with it, extreme event attribution attempts to quantify the contribution of climate change to an extreme event. For example, several groups analyzed the impact of climate change on Hurricane Harvey’s enormous rainfall totals over Houston, Texas and they found that climate change increased rainfall by 15 to 38%. One thing that came up again and again was how terrified fossil-fuel interests are of extreme event attribution science. They are acutely aware that this research could land them in court. And losing those cases would leave them legally liable for billions of dollars in climate damages. Because the legal stakes are so high, the blowback has turned ugly. I spoke with several scientists at the meeting who are facing ongoing harassment over their work. This blowback is a coordinated campaign to make the entire field look suspect. The goal is to create the impression that attribution science is too uncertain, too political, or too conflicted to be useful in court or in public policy. The strategy is not based on actual science or evidence of misconduct, but on the generation of doubt. The new Merchants of Doubt We’ve seen this before. In fact, not that long ago: We only have to go back a year to the Department of Energy (DOE) Climate Working Group (CWG) report to see an example of using doubt as the tool to push back against well-established science. This strategy is laid out in an email from a member of the CWG, Dr. Roy Spencer, that was released during litigation over the Climate Working Group process. The key quote is: About all I can hope is that what we write will provide sufficient “reasonable scientific doubt” regarding the science claims in the 2009 TSD [technical support document], based upon almost 2 decades of new science, to call into question the original reasoning for the EPA Administrator’s decision that CO2 presents a threat to human health and welfare. This statement is strong evidence that at least some members of the committee were working to support a particular policy outcome: revoking the Endangerment Finding. The email also explains how they planned to do it: by attempting to generate “reasonable doubt”. This is going to be hard, Spencer implies. Despite falsely claiming that “2 decades of new science” weakens the case, Spencer explicitly acknowledges that the actual peer-reviewed science of climate change overwhelmingly rejects his position: But if the science argument is decided upon by a vote, or by the number of published citations, we lose the science argument. We can go back even further: This CWG email shares unmistakable DNA with the infamous 1969 tobacco memo that declared: “Doubt is our product, since it is the best means of competing with the ‘body of fact’ that exists in the mind of the general public. It is also the means of establishing a controversy.” The tobacco memo also acknowledges the limit of this strategy: Like the CWG, they knew the science was not on their side. Share The new new Merchants of Doubt The people attacking the IPCC chapter on extreme event attribution are the newest iteration of the Merchants of Doubt. Their goal, like all Merchants before them, is to introduce doubt into the process. Because the report is not even out yet, they cannot attack its conclusions. So they are attacking the authors instead. Here is a press release from the House Science, Space, and Technology Committee: In the letter, the Chairmen express concerns about potential conflicts of interest involving members of the Attribution Committee, stating that “publicly available information suggests a troubling pattern” in which committee members are affiliated with nonprofits that support climate accountability lawsuits, “raising the appearance of impropriety and member bias.” To be clear, this is just innuendo. There is no actual evidence of bias. And given the robust process that these reports go through, including multiple lines of peer review, it seems very unlikely that significant bias can survive into the report. When the report comes out, critics will have the opportunity to make legitimate criticisms of the report — if any exist. If none do, however, they’ll still make criticisms, but they’ll be bogus, simply designed to generate doubt. We’ll see. A note to the press: Fix your frame To any journalists reading this: The public debate over extreme event attribution science is not going away. The science is simply too dangerous to fossil-fuel interests for them to stop fighting it. You very well might be assigned to write an article about this area of research in the future. When you do, do not automatically adopt the framing that climate misinformers want you to use. They want you to frame the story around questions like: Are climate scientists trying to put their thumb on the scale to achieve a predetermined, politically motivated result? Are climate scientists improperly letting their politics invade the science of the IPCC? That frame is a trap. Instead, you need to view this through the historical lens of the Merchants of Doubt. How does the ecosystem of doubt operate? Who funds it? What methods do they use to misrepresent science and slime researchers? What scientific results are they trying to keep people from understanding are legitimate? Ultimately, you instead need to focus your article on the generation of doubt as a way to maintain the fossil fuel industry’s social and legal license to keep burning oil, gas, and coal. If you treat the misinformers’ frame as a legitimate, good-faith scientific critique, you are helping them produce doubt. Don’t do it. Don’t be a Merchant of Doubt. Thanks for reading The Climate Brink! Subscribe for free to receive new posts and support our work. Subscribe other stuff The Staying Curious Substack has an interesting post about the different flavors of climate sensitivity. This is crucial information if you want to understand how scientists think about how much warming the Earth will experience. I’d be grateful if you could hit the like button ❤️ below! It helps more people discover these ideas and lets me know what’s connecting with readers.
Cell and gene therapy's next challenge is not the science, it's everything else
The field's foundational biology is no longer the limiting factor. What comes next depends on whether the industry can build the manufacturing, commercial, and clinical infrastructure to match what the science already knows how to do.
OHIO students, businesses see benefits from participation in Export Internship Program
Ohio University’s participation in the Ohio Export Internship Program Is giving students real-world experience in international trade while also assisting a wide range of manufacturers in the Buckeye State.
Apple's 2028 iPhones to Use 1.4nm A22 Pro Chips
Apple will transition from 2-nanometer chips to 1.4-nanometer chips with the high-end 2028 iPhone models, reports Bloomberg. Chip supplier Taiwan Semiconductor Manufacturing Co. (TSMC) will make the majority of Apple's A22 Pro chips, but Apple is also considering having Intel make some of them. The current iPhone 17 models use a third-generation N3P 3-nanometer process.
Panthers get dissed for 'entertainment' factor in NFL ranking
Will the Carolina Panters be entertaining to watch in 2026?
NASA Uses Machine Learning to Enhance Flash Flood Warnings
The Transient Artifact and Continuous Learning System (TACLS) leverages data from continuously operating satellite networks coupled with machine learning models to help meteorologists at the National Weather Service forecast flash floods more efficiently.
Department of Health and Human Services Digital Stockpile & Manufacturing Response Network Challenge
NASA’s Center of Excellence for Collaborative Innovation (CoECI) assists in the use of crowdsourcing across the federal government. CoECI’s NASA Tournament
Gross Medicaid Prescription Drug Spending
State level data on Gross Medicaid Prescription Drug Spending from KFF, the leading health policy organization in the U.S.
Dave & Buster's Entertainment, Inc. Stock 12‑Month Price Target Cut to $19.78, Implies 61% Upside
Explore more price target data and ratings for Dave & Buster's Entertainment, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Dave & Buster's Entertainment, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet R…
GM Is Not Just a Car Company. It’s Getting Into the Weapons Business.
General Motors and Lockheed Martin are collaborating on using GM’s capacity to manufacture weapons.
Class action lawsuit claims radiology vendor Nano-X Imaging misled investors
The Israel-based manufacturer allegedly made “misleading statements” regarding its business operations and prospects, attorneys charge in the complaint, filed June 12.
Dave & Buster's Entertainment, Inc. Stock 12‑Month Price Target Cut to $20.11, Implies 63% Upside
Explore more price target data and ratings for Dave & Buster's Entertainment, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Dave & Buster's Entertainment, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet R…
The Ceasefire Agreement with Iran Is Not Even Close to a “Deal”
The fact that there’s still a sixty-day window on the table for nuclear negotiations doesn’t really inspire hope.
FBI issues urgent Kali365 security warning for Teams, Outlook, OneDrive users
The agency warned that the hacking platform Kali365 seeks out OAuth device codes, allowing scammers to sneak past multifactor authentication.
Iran agreement: Bad, BATNA or both?
As the debate over a possible Iran agreement shifts from whether there will be a deal to what is in it, commentary is already racing ahead of the facts. We have not yet seen the text. We do not know the precise commitments, timelines or enforcement mechanisms — if any.
Health Insurance Coverage of Adults Ages 19 or Older, Multiple Sources of Coverage
State level data on Health Insurance Coverage of Adults Ages 19 or Older, Multiple Sources of Coverage from KFF, the leading health policy organization in the U.S.
Health Insurance Coverage of Adults Ages 19 or Older
State level data on Health Insurance Coverage of Adults Ages 19 or Older from KFF, the leading health policy organization in the U.S.
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
Key Facts: FDA has accepted for review the New Drug Application (NDA) for an investigational oral suspension formulation of cenobamate for the treatment of...
'We believe in Pedro'
Pedro Porro has signed a new long-term contract with Tottenham, having made 152 appearances since arriving in January 2023 from Sporting CP. "During the past three-and-half years, he has made huge progress to become one of the best full-backs in the game, and the fact he is about to play in the World Cup for Spain is testament to that."
Penn launches $18 million facility to advance RNA technology’s role in health, agriculture
The RNA manufacturing hub opened this spring in University City. The National Science Foundation has invested in five such facilities nationally, each focused on a specific biological material.
Think you know Guy Fieri? Here are 6 facts you might have missed
From a childhood horse mishap to his aversion to eggs, discover what's beneath the rowdy, spiky-haired exterior of Guy Fieri.
How one millennial hit financial independence in three years
"The biggest factor by far, bar none, is the gap between your income and your expenses," says Cody Berman, who hit financial independence at age 25.
'Risk of electrical shock' prompts recall of imaging systems
A handful of fluoroscopy units manufactured by GE HealthCare are the subject of a new recall by the U.S. Food and Drug Administration.